EXPERT COMMITTEE

While addressing a Press Conference on August 06, Assam Chief Minister Himanta Biswa Sarma said that the Expert Committee has been formed to examine the legislative competence of the State Legislature to enact a law to end polygamy in Assam, and sub...

The Reserve Bank of India has decided to keep the key benchmark interest rate - repo rate - unchanged at 6.5 per cent with readiness to act should the situation so warrant, Governor Shaktikanta Das announced on Thursday, after a two-day monetary pol...

The meeting of the GST Council is scheduled for February 18. The agenda is yet to be circulated. The fitment and law committee has examined some subjects. “Finance Minister Nirmala Sitharaman had said that the fitment committee will discuss the impo...

A plea has been moved in the Supreme Court seeking directions to setup a Special Investigation Team (SIT) to enquire about the violent protests against the Agnipath Recruitment Scheme launched by the Govt, and to enquire about the damage caused to t...

As India is witnessing a surge in cases of Omicron variant of coronavirus, taking the total number of infections to 415 in the country, Member of COVID-19 expert committee in Kerala Dr TS Anish on December 24 informed that the number of Omicron case...

The Reserve Bank of India's monetary policy commission on Wednesday voted unanimously to retain the repo rate for the ninth consecutive month. Furthermore, the central bank is also keeping the reverse repo rate and the Marginal Standing Facility unc...

The Supreme Court Wednesday appointed an expert committee to look into allegations of unauthorised surveillance using the Pegasus software. A three-judge bench headed by Chief Justice of India N V Ramana and comprising Justices Surya Kant and Hima K...

The Subject Experts Committee (SEC) of the Drug Controller General of India (DGCI) has granted 'in principle' approval to Bharat Biotech for conduct of 'Phase III superiority study and Phase III booster dose study' trials for its intranasal COVID-19...

The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) on Thursday recommended granting permission for trials of mixing COVID-19 vaccines--Covaxin and Covishield--said sources. As per sources, the application o...

Reserve Bank Governor Shaktikanta Das headed six-member Monetary Policy Committee (MPC) today announced the policy resolution. The MPC maintained the status quo on the benchmark interest rate or repo rate at 4%. It is the tenth consecutive time sinc...

Subject Expert Committee has approved Bharat Biotech's covid vaccine 'COVAXIN' for children in the 2-18 age group. DCGI will now to take the final call. As part of the Phase II/III trial, the two-dose Covaxin was administered to 525 children 28 days...

India’s drug regulator has given permission to Zydus Cadila for conducting Phase III trial on the two-dose regimen of its needle-free Covid-19 vaccine, ZyCoV-D. In a meeting held last month, the Subject Expert Committee (SEC), which advises the drug...

The Supreme Court on Thursday orally observed that it would be setting up a technical expert committee to inquire into the Pegasus snooping matter, and an order will be passed next week on a batch of pleas seeking an independent probe into the issue...

The Subject Expert Committee (SEC) has approved the Phase -3 trial data of Bharat Biotech's Covaxin that was conducted on 25,800 subjects. The data on India's only homegrown Covid-19 vaccine has shown 77.8% efficacy. The Hyderabad-based vaccine make...

DCGI accepts recommendations of Subject Expert Committee (SEC) to no longer administer Covaxin in 'clinical trial mode'. The SEC of Drugs Controller General of India (DCGI) on Wednesday recommended removing the "clinical trial mode" condition relate...

A day after the Subject Expert Committee gave a go-ahead to SII, Oxford-Astrazeneca vaccine candidate-Covishield, the expert panel today recommended Bharat Biotech’s Covaxin too for restricted emergency use, government sources have confirmed. The Dr...

Subject Expert Committee (SEC) gave nod to Bharat Biotech’s ‘Covaxin’ for phase 2 and 3 human clinical trials on 2 to 18 years. In the ongoing vaccination drive in India, the ‘Covaxin’ is being used in adults. ‘Covaxin’ is one of the two vaccines be...

India today gave approval to Sputnik V, its third Covid-19 vaccine after Covishield and Covaxin. This will boost India's vaccination drive as more and more cases are being reported every day. DCGI will give the final go ahead for the vaccine roll ou...